#3 - CVS Health (NYSE:CVS)
CVS Health (NYSE:CVS) stock looks to be another winner as the vaccine distribution gets underway. The company, along with Walgreens Boots Alliance (NASDAQ:WBA) is hiring thousands of pharmacists and technicians to undertake the task of administering the vaccine. This is in sharp contrast to the mass layoffs that took place over the summer.
This will not only be taking place at the pharmacy chain’s retail locations. CVS is also one of the companies that will be going to long-term care facilities to ensure the vaccine is administered to those in our most vulnerable population.
To be clear, this may be a short-term play on an undervalued stock. CVS Health faces a genuine threat from Amazon as it moves into the pharmacy space. However, people's need to set foot inside a pharmacy to get a shot may give CVS a chance to prove that its renovation process can pay off with additional revenue.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More - Current Price
- $59.60
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 13 Buy Ratings, 10 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $75.05 (25.9% Upside)
